Forgot your password?
Document Actions
Implicit Decision-Making in the Treatment of Invisible Disease
People with early-stage breast cancer are given chemotherapy to reduce the risk of subsequent recurrence and death. Full doses are required for full benefit, yet many patients receive reduced doses of chemotherapy. Implicit decision-making on the part of physicians may account for dose reductions in many cases. This talk will describe the systematic under dosing of chemotherapy in black women, poor women, and obese women and present possible explanations for dose reductions as well as the implications of dose reductions in populations.
2009-09-17 00:00
2009-09-17 12:00
2009-09-17 13:30
Jennifer J. Griggs, MD, MPH
Jennifer Griggs is Associate Professor of Medicine in the Division of Hematology/Oncology. A medical oncologist with a practice focused on the care of women with breast cancer, her research program focuses on quality of and disparities in cancer care.
6D15 NIB (new room for 2009)
http://wocket.chcr.med.umich.edu/chcr/seminars/2009-09-17-griggs.htm
griggs_17_Sept_2009_materials.pdf
(
Upcoming Seminar - December 17th: Laurel Northouse
